The risk and outcomes of pneumonia in patients on inhaled corticosteroids
Por:
Sibila, O, Soto-Gomez, N, Restrepo, MI
Publicada:
1 jun 2015
Resumen:
Corticosteroids are frequently prescribed anti-inflammatory medications. Inhaled corticosteroids (ICS) are indicated for Chronic Obstructive Pulmonary Disease (COPD) and asthma. ICS are associated with a decrease in exacerbations and improved quality of life in COPD, however multiple studies have linked the chronic use of ICSs with an increased risk of developing pneumonia, though the effect on mortality is unclear. We review the association of ICS with the risk of pneumonia and the implications on clinical outcomes. Published by Elsevier Ltd.
Filiaciones:
Sibila, O:
Hosp Santa Creu & Sant Pau, Serv Pneumol, Barcelona 08025, Spain
St Antoni Maria Claret, Inst Invest Biomed St Pau IBB St Pau, Barcelona 08025, Spain
Soto-Gomez, N:
South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA
Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
Restrepo, MI:
South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA
Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
Green Accepted
|